Sophia Genetics, a specialist in data-driven medicine, has raised $13.75m in its series B. The round was led by Invoke Capital, which was joined by Swisscom and Endeavour Vision.
Apart from the cash injection, Sophia gains access to Invoke’s portfolio company Genalys, which uses big data mathematics to analyse genomic information.
Spun out of the Federal Institute of Technology Lausanne in 2011, the Swiss company’s technology makes it possible to diagnose genetic diseases and the DNA of cancer tumours through a combination of next generation sequencing and highly accurate and scalable predictive algorithms. It is hoped that now that Sophia and Genalys have access to each other’s expertise, the technology can be improved even further.
Sophia Genetics previously raised $2.8m in 2013 from undisclosed investors. The company is ahead of its competition in that it is already fully compliant with European data privacy laws. Its technology is currently patent-pending.
Invoke Capital is a $1bn fund launched by founder of Cambridge spin-out Autonomy Mike Lynch, and invests in university spin-outs.
Jurgi Camblong, CEO of Sophia Genetics, said: “Medicine is changing and I am proud of all the work Sophia Genetics is doing to improve diagnosis and treatment of diseases. This new funding will allow us to move faster into European markets. Invoke Capital in particular provides a degree of expertise in data security in cloud and in scalability that will strengthen our genetic sequencing data banking offering immediately.”

- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- Video
- Subscribe
- Newsletters
- Events
Invoke Capital leads Sophia’s series B
Jul 9, 2014 •
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.More featured content
Venture fund launched to invest in German business programme CDTM startups The small German academic institution generates an outsize number of unicorns.Venture fund launched to invest in German business programme CDTM startups
The small German academic institution generates an outsize number of unicorns.
Entrepreneur vs academic: Who makes the best leader of a spinout? Professors have academic teaching obligations that can distract them from leading a spinout, but their technical expertise is also often invaluable to its commercial success.Entrepreneur vs academic: Who makes the best leader of a spinout?
Professors have academic teaching obligations that can distract them from leading a spinout, but their technical expertise is also often invaluable to its commercial success.
Knowles joins Australian university venture fund Uniseed Aleta Knowles was a former member of the Uniseed investment committee during her time at University of New South Wales.Knowles joins Australian university venture fund Uniseed
Aleta Knowles was a former member of the Uniseed investment committee during her time at University of New South Wales.
About us
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.